TD Cowen: 'We Continue to See United Therapeutics Corp. (UTHR) Shares as Undervalued'
Tweet Send to a Friend
TD Cowen analyst Joseph Thome reiterated a Buy rating and $400.00 price target on United Therapeutics Corp. (NASDAQ: UTHR).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
